EFFICACY OF USTEKINUMAB IN CROHN'S DISEASE AT MAINTENENCE WEEK 56: IM-UNITI STUDY

被引：0
|
作者：
Sandborn, William J.
Sands, Bruce E.
Colombel, Jean-Frederic
Gasink, Christopher
Patel, Rishit
Jacobstein, Douglas
Gao, Long-long
Ghosh, Subrata
Targan, Stephan
De Villiers, Willem
Hanauer, Stephen B.
Rutgeerts, Paul
Feagan, Brian G.
机构：
来源：
INFLAMMATORY BOWEL DISEASES | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P034
引用
收藏
页码：S16 / S17
页数：2
相关论文
共 50 条
  • [1] EFFICACY OF USTEKINUMAB IN CROHN'S DISEASE AT MAINTENENCE WEEK 56: IM-UNITI STUDY
    Sandborn, William J.
    Sands, Bruce E.
    Colombel, Jean-Frederic
    Gasink, Christopher
    Patel, Rishit
    Jacobstein, Douglas
    Gao, Long-long
    Ghosh, Subrata
    Targan, Stephan
    De Villiers, Willem
    Hanauer, Stephen B.
    Rutgeerts, Paul
    Feagan, Brian G.
    GASTROENTEROLOGY, 2019, 156 (03) : S23 - S24
  • [2] Efficacy of ustekinumab in Crohn's disease at maintenance Week 56: IM-UNITI study
    Sandborn, W. J.
    Sands, B.
    Colombel, J. -F.
    Gasink, C.
    Patel, R.
    Jacobstein, D.
    Gao, L. -L.
    Ghosh, S.
    Targan, S.
    De Villiers, W.
    Hanauer, S. B.
    Rutgeerts, P.
    Feagan, B.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S274 - S274
  • [3] IMMUNOGENICITY OF USTEKINUMAB IN PATIENTS WITH CROHN'S DISEASE: RESULTS FROM THE IM-UNITI STUDY
    Sandborn, William J.
    Sands, Bruce E.
    Nussbaum, Jeannette
    Oortwijn, Alessandra
    Gasink, Christopher
    Jacobstein, Douglas
    Gao, Long-Long
    Adedokun, Omoniyi J.
    de Villiers, Willem J.
    Ghosh, Subrata
    GASTROENTEROLOGY, 2019, 156 (06) : S1097 - S1097
  • [4] IM-UNITI: Three-year Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn's Disease
    Hanauer, Stephen B.
    Sandborn, William J.
    Feagan, Brian G.
    Gasink, Christopher
    Jacobstein, Douglas
    Zou, Bin
    Johanns, Jewel
    Adedokun, Omoniyi J.
    Sands, Bruce E.
    Rutgeerts, Paul
    de Villiers, Willem J. S.
    Colombel, Jean-Frederic
    Ghosh, Subrata
    JOURNAL OF CROHNS & COLITIS, 2020, 14 (01): : 23 - 32
  • [5] Five-Year Efficacy and Safety of Ustekinumab Treatment in Crohn's Disease: The IM-UNITI Trial
    Sandborn, William J.
    Rebuck, Rory
    Wang, Yuhua
    Zou, Bin
    Adedokun, Omoniyi J.
    Gasink, Christopher
    Sands, Bruce E.
    Hanauer, Stephen B.
    Targan, Stephan
    Ghosh, Subrata
    de Villiers, Willem J. S.
    Colombel, Jean-Frederic
    Feagan, Brian G.
    Lynch, John P.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (03) : 578 - +
  • [6] IM-UNITI at Three Years: Stellar Stelara® or Stardust? The Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn's Disease
    Travis, Simon
    JOURNAL OF CROHNS & COLITIS, 2020, 14 (01): : 1 - 3
  • [7] Efficacy, Safety and Timing of Dose Adjustment of Subcutaneous Ustekinumab Maintenance in Moderate -Severe Crohn's Disease Patients in IM-UNITI
    Bruce, Sands
    Christopher, Gasink
    Douglas, Jacobstein
    Gao Long-Long
    Jewel, Johanns
    Philippe, Szapary
    Jean-Frederic, Colombel
    Stephan, Targan
    Subrata, Ghosh
    William, Sandborn
    INFLAMMATORY BOWEL DISEASES, 2017, 23 : S9 - S9
  • [8] Efficacy and Safety of Ustekinumab for Crohn's Disease: Results From IM-UNITI Long-Term Extension Through 3 Years
    Sandborn, William J.
    Rutgeerts, Paul
    Jacobstein, Douglas
    Gasink, Christopher
    Patel, Reese
    Zou, Bin
    Johanns, Jewel
    Sands, Bruce E.
    Hanauer, Stephen
    Targan, Stephan
    Ghosh, Subrata
    de Villiers, Willem
    Colombel, Jean-Frederic
    Feagan, Brian
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S345 - S346
  • [9] Efficacy and Safety of Dose Adjustment and Delayed Response to Ustekinumab in Moderate - Severe Crohn's Disease Patients: Results from the IM-UNITI Maintenance Study
    Sands, Bruce
    Gasink, Chris
    Jacobstein, Doug
    Gao, Long Long
    Johanns, Jewel
    Szapary, Philippe
    Colombel, Jean-Frederic
    Targan, Stephan
    Ghosh, Subrata
    Sandborn, William J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S302 - S303
  • [10] Body Mass Index Does Not Impact Clinical Efficacy of Ustekinumab in Crohn's Disease: A Post Hoc Analysis of the IM-UNITI Trial
    Wong, Emily C. L.
    Marshall, John K.
    Reinisch, Walter
    Narula, Neeraj
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (06) : 848 - 854
12345